(2023)
Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies.
CLINICAL IMAGING.
101,
(2022)
Utility of Diffusion-Weighted MRI for Detection of Locally Recurrent Pancreatic Cancer After Surgical Resection.
AMERICAN JOURNAL OF ROENTGENOLOGY.
219,
5
(2022)
Association between intensity of imaging surveillance and clinical outcomes in patients with hepatocellular carcinoma.
EUROPEAN JOURNAL OF RADIOLOGY.
151,
(2022)
A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
EUROPEAN RADIOLOGY.
32,
2
(2021)
EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC.
LIVER INTERNATIONAL.
41,
12
(2021)
Prognosis after curative resection of single hepatocellular carcinoma with a focus on li-rads targetoid appearance on preoperative gadoxetic acid-enhanced mri.
KOREAN JOURNAL OF RADIOLOGY.
22,
11
(2021)
Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT.
EUROPEAN RADIOLOGY.
31,
10
(2021)
Intraindividual Comparison of Hepatocellular Carcinoma Washout between MRIs with Hepatobiliary and Extracellular Contrast Agents.
KOREAN JOURNAL OF RADIOLOGY.
22,
5
(2021)
Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
EUROPEAN RADIOLOGY.
31,
5
(2021)
Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor.
EUROPEAN JOURNAL OF RADIOLOGY.
135,
(2021)
Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
EUROPEAN RADIOLOGY.
31,
7
(2021)
Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
RADIOLOGY.
298,
1
(2021)
Quantitative analysis of contrast-enhanced ultrasonography following living donor liver transplantation: Early diagnosis of middle hepatic venous occlusion.
MEDICAL ULTRASONOGRAPHY.
23,
4
(2020)
Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines.
ABDOMINAL RADIOLOGY.
45,
12
(2020)
Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY.
18,
9
(2020)
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
RADIOLOGY.
296,
2
(2020)
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.
EUROPEAN RADIOLOGY.
30,
7
(2020)
Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category.
CLINICAL RADIOLOGY.
75,
6
(2020)
Comparison of the diagnostic performance of the 2017 and 2018 versions of LI-RADS for hepatocellular carcinoma on gadoxetic acid enhanced MRI.
CLINICAL RADIOLOGY.
75,
4
(2020)
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
KOREAN JOURNAL OF RADIOLOGY.
21,
4
학술회의논문
(2020)
Abdomen Symposium 2 좌장.
ASMRM&ICMRI 2020.
대한민국
(2020)
Comparison of HBA and ECCM in HCC diagnosis.
ASMRM&ICMRI 2020.
대한민국
(2020)
Detection of locally recurrent pancreatic cancer after surgical resection: added value of diffusion-weighted MRI.
KCR 2020.
대한민국
(2019)
Extracellular Contrast-Enhanced MRI with Diffusion-Weighted Imaging for HCC Diagnosis: Prospective Comparison with Gadoxetic Acid.
RSNA 2019.
미국
(2019)
Prospective Intraindividual Comparison of CT, MRI with Extracellular Contrast and Gadoxetic Acid for Diagnosis of HCC.
RSNA 2019.
미국
(2019)
Robustness of extracellular contrast-enhanced MRI in HCC diagnosis.
KCR 2019.
대한민국
(2019)
Diagnosis of Hepatocellular Carcinoma: Extracellular contrast agent vs. Hepatocyte agent.
ICMRI 2019.
대한민국
(2018)
MRI: How to easily perform and interpret liver MRI?.
복영회 연수교육 복부영상기법.
대한민국
(2018)
Diagnosis of hepatocellular carcinoma: Extracellular contrast agent vs.hepatocyte agent.
KCR 2018.
대한민국
(2018)
Diagnosis of Hepatocellular Carcinoma: Extracellular Agent Vs. Hepatocyte Agent.
GEM 2018.
태국
(2018)
Prospective intraindividual comparison of Gd-EOB-DTPA and Gd-DOTA for diagnosis of hepatocellular carcinomas with LI-RADS.
ESGAR 2018.
아일랜드
(2018)
Dynamic contrast-enhanced liver MRI: clinical perspectives.
ICMRI 2018.
대한민국
(2017)
Artifacts during the arterial phase of gadoxetate disodium-enhanced MR imaging: multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging.
KCR 2017.
대한민국
(2017)
Hepatic tumor: prediction of invasiveness.
KCR 2017.
대한민국
(2017)
Adding Intratumoral Pathomorphologic Ancillary Features to Conventional Enhancement Patterns of Hepatocellular Carcinoma on Gadoxetic Acid-enhanced MR imaging Improves Diagnostic Performance.
ESGAR 2017.
그리스
(2016)
Imaging diagnosis of HCC: Made it easy.
ACTA 2016.
대한민국
(2016)
HCC / Cholangiocellular Carcinoma.
APLIS 2016.
중국
(2016)
Added value of capsule, septum, and T2 hyperintense foci in the differentiation between atypical hepatocellular carcinoma and cholangiocarcinoma with gadoxetic acid MR imaging.
KCR 2016.
대한민국
(2016)
Differentiating acute-on-chronic liver failure from chronic liver disease: emphasize on quantitative signal intensity analysis of T2-weighted images.
KCR 2016.
대한민국
(2016)
Imaging findings of mimickers of hepatic malignancies.
ISTS 2016.
대한민국
